Segment Information (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table illustrates information about segment revenues, significant segment expenses, and segment net income (loss) for the three months ended March 31, 2025 and 2024 (in thousands):

	Three Months Ended March 31,
	2025		2024
Revenues	$	145,534	$	92,761
Less1:
Cost of product sales	4,568		1,265
Research and development
Berotralstat	7,825		11,958
Factor D Program	1,489		10,480
BCX17725	7,308		7,759
Other research, preclinical and development costs	20,648		16,296
Selling, general and administrative	82,469		59,491
Foreign currency (gains) losses, net	(1)		51
Interest income	(3,024)		(4,031)
Interest expense	23,494		24,506
Income tax expense	726		365
Segment net income (loss)	32		(35,379)
Reconciliation of segment profit or loss:
Adjustments and reconciling items	—		—
Consolidated net income (loss)	$	32	$	(35,379)
1 The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.